ClinVar Miner

Submissions for variant NM_030662.4(MAP2K2):c.1020C>T (p.Pro340=)

gnomAD frequency: 0.00009  dbSNP: rs192389729
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen RASopathy Variant Curation Expert Panel RCV000233235 SCV000616565 benign RASopathy 2017-05-09 reviewed by expert panel curation The filtering allele frequency of the c.1020C>T (p.Pro340=) variant in the MAP2K2 gene is 0.262% (29/7910) of South Asian chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BA1; PMID:29493581)
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000039469 SCV000063153 benign not specified 2011-02-18 criteria provided, single submitter clinical testing This variant is not expected to have clinical significance because it does not a lter an amino acid residue and is not located near a splice junction.
Invitae RCV000233235 SCV000290939 benign RASopathy 2024-01-02 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001813364 SCV002060567 benign Noonan syndrome and Noonan-related syndrome 2021-04-06 criteria provided, single submitter clinical testing
Ambry Genetics RCV002381315 SCV002670421 likely benign Cardiovascular phenotype 2022-04-03 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
CeGaT Center for Human Genetics Tuebingen RCV003415776 SCV004141445 likely benign not provided 2023-02-01 criteria provided, single submitter clinical testing MAP2K2: BP4, BP7, BS1
PreventionGenetics, part of Exact Sciences RCV003944927 SCV004760172 benign MAP2K2-related condition 2020-04-27 criteria provided, single submitter clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.